Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
Crossref DOI link: https://doi.org/10.1007/s13277-014-2553-1
Published Online: 2014-09-05
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vallius, Tuulia
Hynninen, Johanna
Auranen, Annika
Carpén, Olli
Matomäki, Jaakko
Oksa, Sinikka
Virtanen, Johanna
Grénman, Seija
Text and Data Mining valid from 2014-09-05